H&T Presspart has acquired Swiss device maker Novelex (formerly Forteq Nidau), the company said, and all Novelex employees will be absorbed into H&T Presspart. The company acquired Novelex from Liberta Partners, which had acquired Forteq Nidau in November 2020.
Two partners from Liberta Partners, Florian Korp and Peter Franke, commented, “H&T Presspart is the right industry partner to Novelex and its employees with the ability to create strong synergies. We are honored to have accompanied Novelex and thereby helped to strengthen its excellent niche market position.”
H&T Presspart President Christian Krätzig said, “Novelex’s business is an excellent strategic fit. The acquisition will open up new opportunities to accelerate growth. Novelex‘s extensive experience in the delivery of high-quality components and devices for pharmaceutical clients complements our offering and capabilities in the growing drug delivery device market.”
In 2019, H&T Presspart opened a new injection molding facility in Tarragona, Spain, where it manufactures MDI actuators and DPIs. The company also has inhaler component manufacturing facilities in Blackburn, UK and Marsberg, Germany.
Read the H&T Presspart press release.
